- Home
- MKTX vs CORT Comparison
MKTX vs CORT Comparison
Compare MKTX & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKTX
- CORT
- Stock Information
- Founded
- MKTX 2000
- CORT 1998
- Country
- MKTX United States
- CORT United States
- Employees
- MKTX N/A
- CORT N/A
- Industry
- MKTX Investment Bankers/Brokers/Service
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- MKTX Finance
- CORT Health Care
- Exchange
- MKTX Nasdaq
- CORT Nasdaq
- Market Cap
- MKTX 8.1B
- CORT 7.1B
- IPO Year
- MKTX 2004
- CORT N/A
- Fundamental
- Price
- MKTX $215.57
- CORT $75.08
- Analyst Decision
- MKTX Buy
- CORT Strong Buy
- Analyst Count
- MKTX 9
- CORT 4
- Target Price
- MKTX $241.78
- CORT $142.00
- AVG Volume (30 Days)
- MKTX 538.0K
- CORT 1.3M
- Earning Date
- MKTX 05-07-2025
- CORT 05-05-2025
- Dividend Yield
- MKTX 1.41%
- CORT N/A
- EPS Growth
- MKTX N/A
- CORT 8.36
- EPS
- MKTX 5.76
- CORT 1.14
- Revenue
- MKTX $815,355,000.00
- CORT $685,446,000.00
- Revenue This Year
- MKTX $8.13
- CORT $35.85
- Revenue Next Year
- MKTX $9.86
- CORT $35.22
- P/E Ratio
- MKTX $37.31
- CORT $65.80
- Revenue Growth
- MKTX 7.33
- CORT 30.93
- 52 Week Low
- MKTX $186.84
- CORT $25.35
- 52 Week High
- MKTX $296.68
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- MKTX 44.61
- CORT 57.68
- Support Level
- MKTX $209.80
- CORT $68.86
- Resistance Level
- MKTX $232.84
- CORT $73.36
- Average True Range (ATR)
- MKTX 6.33
- CORT 3.26
- MACD
- MKTX -1.80
- CORT 0.12
- Stochastic Oscillator
- MKTX 21.79
- CORT 95.28
About MKTX MarketAxess Holdings Inc.
Founded in 2000, MarketAxess is a leading electronic fixed-income trading platform that connects broker/dealers and institutional investors. The company is primarily focused on credit based fixed income securities with its main trading products being US investment-grade and high-yield bonds, Eurobonds, and Emerging Market corporate debt. Recently the company has expanded more aggressively into Treasuries and municipal bonds with the acquisitions of LiquidityEdge and MuniBrokers in 2019 and 2021, respectively. The company also provides pre- and post-trade services with its acquisition of Regulatory Reporting Hub from Deutsche Börse Group in 2020 adding to its product offerings.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.